CN Patent

CN111201218A — 一种哌马色林半酒石酸盐的新晶型及其制备方法

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2020-05-26 · 6y expired

What this patent protects

本发明提供了一种哌马色林半酒石酸盐的新晶型及其制备方法，属于药物化学领域。所述晶型的XRPD图在2θ(误差±0.2度)含有如下特征峰：5.37,7.02,10.62,14.07,16.79,18.66,20.60,21.65。所述晶型具有较好的溶解性，稳定性，有利于储存、转移、生产工艺中操作，可以用于制备成药物制剂。

USPTO Abstract

本发明提供了一种哌马色林半酒石酸盐的新晶型及其制备方法，属于药物化学领域。所述晶型的XRPD图在2θ(误差±0.2度)含有如下特征峰：5.37,7.02,10.62,14.07,16.79,18.66,20.60,21.65。所述晶型具有较好的溶解性，稳定性，有利于储存、转移、生产工艺中操作，可以用于制备成药物制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN111201218A
Jurisdiction
CN
Classification
—
Expires
2020-05-26
Drug substance claim
No
Drug product claim
No
Assignee
Sunshine Lake Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.